Amicus Therapeutics: Strong Catalyst Trade With GlaxoSmithKline And Heavy Insider Buying
10:07 EDT 2 Aug 2012 | Thomson Reuters
This article has expired, however you can still
download the PDF.
Preview:
By Scott Matusow, ContributorI like to invest in and trade companies with strong corporate structures that are also equipped with upcoming short term catalysts. One company that has been receiving some interest in the investment community demonstrates bot...
Other Sources for this Article
More From BioPortfolio on "Amicus Therapeutics: Strong Catalyst Trade With GlaxoSmithKline And Heavy Insider Buying"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
